ABUSCREEN ONTRAK FOR COCAINE (200NG/ML)

Radioimmunoassay, Cocaine Metabolite

ROCHE DIAGNOSTIC SYSTEMS, INC.

The following data is part of a premarket notification filed by Roche Diagnostic Systems, Inc. with the FDA for Abuscreen Ontrak For Cocaine (200ng/ml).

Pre-market Notification Details

Device IDK905730
510k NumberK905730
Device Name:ABUSCREEN ONTRAK FOR COCAINE (200NG/ML)
ClassificationRadioimmunoassay, Cocaine Metabolite
Applicant ROCHE DIAGNOSTIC SYSTEMS, INC. ONE SUNSET AVE. Montclair,  NJ  07042
ContactCarol L Krieger
CorrespondentCarol L Krieger
ROCHE DIAGNOSTIC SYSTEMS, INC. ONE SUNSET AVE. Montclair,  NJ  07042
Product CodeKLN  
CFR Regulation Number862.3250 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1990-12-24
Decision Date1991-01-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.